Merck in diabetes and discovery deals

Probiodrug (Halle/Saale, Germany) granted MRK exclusive worldwide rights to its dipeptidyl peptidase IV (DPP IV) enzyme inhibitors, for use in developing therapeutics to treat diabetes and related dis...